Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1/2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd
0 Patents (Medical) associated with Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd
100 Deals associated with Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd
100 Translational Medicine associated with Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd